Literature DB >> 33404704

The distribution and chemical coding of enteroendocrine cells in Trypanosoma cruzi-infected individuals with chagasic megacolon.

Patrícia Rocha Martins1, Josiane Fakhry2, Adriana Jacaúna de Oliveira3, Thayse Batista Moreira3, Linda J Fothergill2,4, Enio Chaves de Oliveira5, Débora d'Ávila Reis6, John B Furness2,4.   

Abstract

Chagas disease is caused by the parasite, Trypanosoma cruzi that causes chronic cardiac and digestive dysfunction. Megacolon, an irreversible dilation of the left colon, is the main feature of the gastrointestinal form of Chagas disease. Patients have severe constipation, a consequence of enteric neuron degeneration associated with chronic inflammation. Dysmotility, infection, neuronal loss and a chronic exacerbated inflammation, all observed in Chagas disease, can affect enteroendocrine cells (EEC) expression, which in turn, could influence the inflammatory process. In this study, we investigated the distribution and chemical coding of EEC in the dilated and non-dilated portion of T. cruzi-induced megacolon and in non-infected individuals (control colon). Using immunohistochemistry, EECs were identified by applying antibodies to chromogranin A (CgA), glucagon-like peptide 1 (GLP-1), 5-hydroxytryptamine (5-HT), peptide YY (PYY) and somatostatin (SST). Greater numbers of EEC expressing GLP-1 and SST occurred in the dilated portion compared to the non-dilated portion of the same patients with Chagas disease and in control colon, but numbers of 5-HT and PYY EEC were not significantly different. However, it was noticeable that EEC in which 5-HT and PYY were co-expressed were common in control colon, but were rare in the non-dilated and absent in the dilated portion of chagasic megacolon. An increase in the number of CgA immunoreactive EEC in chagasic patients reflected the increases in EEC numbers summarised above. Our data suggests that the denervation and associated chronic inflammation are accompanied by changes in the number and coding of EEC that could contribute to disorders of motility and defence in the chagasic megacolon.

Entities:  

Keywords:  Chagas disease; Chagasic megacolon; Enteroendocrine cells; Gastrointestinal hormones

Year:  2021        PMID: 33404704     DOI: 10.1007/s00418-020-01947-w

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  64 in total

1.  Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis.

Authors:  S J Adad; C G Cançado; R M Etchebehere; V P Teixeira; U A Gomes; E Chapadeiro; E R Lopes
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

2.  The oral transmission of Chagas' disease: an acute form of infection responsible for regional outbreaks.

Authors:  Paulo Roberto Benchimol Barbosa
Journal:  Int J Cardiol       Date:  2006-04-05       Impact factor: 4.164

3.  Identification of enteroendocrine cells that express TRPA1 channels in the mouse intestine.

Authors:  Hyun-Jung Cho; Brid Callaghan; Romke Bron; David M Bravo; John B Furness
Journal:  Cell Tissue Res       Date:  2014-01-18       Impact factor: 5.249

4.  Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells.

Authors:  Y Chowers; L Cahalon; M Lahav; H Schor; R Tal; S Bar-Meir; M Levite
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

5.  Differences in hormone localisation patterns of K and L type enteroendocrine cells in the mouse and pig small intestine and colon.

Authors:  Hyun-Jung Cho; Samin Kosari; Billie Hunne; Brid Callaghan; Leni R Rivera; David M Bravo; John B Furness
Journal:  Cell Tissue Res       Date:  2014-11-07       Impact factor: 5.249

Review 6.  5-HT and the immune system.

Authors:  Gerard P Ahern
Journal:  Curr Opin Pharmacol       Date:  2011-03-08       Impact factor: 5.547

7.  Immunohistochemical study on the neuroendocrine system of the digestive tract of turbot, Scophthalmus maximus (L.), infected by Enteromyxum scophthalmi (Myxozoa).

Authors:  R Bermúdez; F Vigliano; M I Quiroga; J M Nieto; G Bosi; C Domeneghini
Journal:  Fish Shellfish Immunol       Date:  2006-06-08       Impact factor: 4.581

8.  Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor.

Authors:  Patricia L Brubaker; Daniel J Drucker; Sylvia L Asa; Carol Swallow; Mark Redston; Gordon R Greenberg
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

Review 9.  Evaluation and treatment of chagas disease in the United States: a systematic review.

Authors:  Caryn Bern; Susan P Montgomery; Barbara L Herwaldt; Anis Rassi; Jose Antonio Marin-Neto; Roberto O Dantas; James H Maguire; Harry Acquatella; Carlos Morillo; Louis V Kirchhoff; Robert H Gilman; Pedro A Reyes; Roberto Salvatella; Anne C Moore
Journal:  JAMA       Date:  2007-11-14       Impact factor: 56.272

10.  Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures.

Authors:  Connie Chisholm; Gordon R Greenberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-08       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.